nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—BCHE—Triamcinolone—ankylosing spondylitis	0.427	0.455	CbGbCtD
Neostigmine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.143	0.152	CbGbCtD
Neostigmine—ABCB1—Betamethasone—ankylosing spondylitis	0.093	0.099	CbGbCtD
Neostigmine—ABCB1—Prednisolone—ankylosing spondylitis	0.0918	0.0977	CbGbCtD
Neostigmine—ABCB1—Prednisone—ankylosing spondylitis	0.0867	0.0923	CbGbCtD
Neostigmine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0541	0.0576	CbGbCtD
Neostigmine—ABCB1—Methotrexate—ankylosing spondylitis	0.0435	0.0463	CbGbCtD
Neostigmine—Abnormal behaviour—Methylprednisolone—ankylosing spondylitis	0.00226	0.0372	CcSEcCtD
Neostigmine—Wheezing—Triamcinolone—ankylosing spondylitis	0.000821	0.0135	CcSEcCtD
Neostigmine—Paralysis—Methotrexate—ankylosing spondylitis	0.000803	0.0132	CcSEcCtD
Neostigmine—Osteoarthritis—Prednisolone—ankylosing spondylitis	0.000667	0.011	CcSEcCtD
Neostigmine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.000634	0.0104	CcSEcCtD
Neostigmine—Osteoarthritis—Triamcinolone—ankylosing spondylitis	0.000613	0.0101	CcSEcCtD
Neostigmine—Osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.000612	0.01	CcSEcCtD
Neostigmine—Dysarthria—Methotrexate—ankylosing spondylitis	0.00059	0.00969	CcSEcCtD
Neostigmine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.000583	0.00958	CcSEcCtD
Neostigmine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.000582	0.00956	CcSEcCtD
Neostigmine—Sweating increased—Prednisolone—ankylosing spondylitis	0.000562	0.00922	CcSEcCtD
Neostigmine—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.000557	0.00914	CcSEcCtD
Neostigmine—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.000557	0.00914	CcSEcCtD
Neostigmine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000529	0.00869	CcSEcCtD
Neostigmine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000529	0.00869	CcSEcCtD
Neostigmine—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00052	0.00854	CcSEcCtD
Neostigmine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.000516	0.00848	CcSEcCtD
Neostigmine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.000515	0.00846	CcSEcCtD
Neostigmine—Coma—Methotrexate—ankylosing spondylitis	0.00051	0.00837	CcSEcCtD
Neostigmine—Osteoarthritis—Prednisone—ankylosing spondylitis	0.000485	0.00796	CcSEcCtD
Neostigmine—Bradycardia—Prednisolone—ankylosing spondylitis	0.00047	0.00771	CcSEcCtD
Neostigmine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.000469	0.00769	CcSEcCtD
Neostigmine—Sweating increased—Betamethasone—ankylosing spondylitis	0.000469	0.00769	CcSEcCtD
Neostigmine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000461	0.00757	CcSEcCtD
Neostigmine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000432	0.00709	CcSEcCtD
Neostigmine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000431	0.00708	CcSEcCtD
Neostigmine—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000416	0.00683	CcSEcCtD
Neostigmine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000412	0.00677	CcSEcCtD
Neostigmine—Sweating increased—Prednisone—ankylosing spondylitis	0.000408	0.0067	CcSEcCtD
Neostigmine—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000405	0.00665	CcSEcCtD
Neostigmine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000392	0.00644	CcSEcCtD
Neostigmine—Bradycardia—Betamethasone—ankylosing spondylitis	0.000392	0.00644	CcSEcCtD
Neostigmine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000382	0.00627	CcSEcCtD
Neostigmine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000379	0.00622	CcSEcCtD
Neostigmine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000378	0.00621	CcSEcCtD
Neostigmine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000371	0.00609	CcSEcCtD
Neostigmine—Syncope—Prednisolone—ankylosing spondylitis	0.00036	0.00591	CcSEcCtD
Neostigmine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000353	0.0058	CcSEcCtD
Neostigmine—Convulsion—Prednisolone—ankylosing spondylitis	0.000348	0.00571	CcSEcCtD
Neostigmine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000344	0.00565	CcSEcCtD
Neostigmine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000344	0.00565	CcSEcCtD
Neostigmine—Bradycardia—Prednisone—ankylosing spondylitis	0.000341	0.0056	CcSEcCtD
Neostigmine—Syncope—Triamcinolone—ankylosing spondylitis	0.000331	0.00544	CcSEcCtD
Neostigmine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000331	0.00543	CcSEcCtD
Neostigmine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000329	0.00541	CcSEcCtD
Neostigmine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000328	0.00538	CcSEcCtD
Neostigmine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000325	0.00533	CcSEcCtD
Neostigmine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000324	0.00532	CcSEcCtD
Neostigmine—Shock—Prednisolone—ankylosing spondylitis	0.000323	0.0053	CcSEcCtD
Neostigmine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00032	0.00526	CcSEcCtD
Neostigmine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00032	0.00525	CcSEcCtD
Neostigmine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000319	0.00524	CcSEcCtD
Neostigmine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000317	0.0052	CcSEcCtD
Neostigmine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000314	0.00515	CcSEcCtD
Neostigmine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000312	0.00513	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000312	0.00512	CcSEcCtD
Neostigmine—Flushing—Prednisone—ankylosing spondylitis	0.000311	0.00511	CcSEcCtD
Neostigmine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000308	0.00505	CcSEcCtD
Neostigmine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000301	0.00495	CcSEcCtD
Neostigmine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000301	0.00494	CcSEcCtD
Neostigmine—Syncope—Dexamethasone—ankylosing spondylitis	0.000301	0.00494	CcSEcCtD
Neostigmine—Syncope—Betamethasone—ankylosing spondylitis	0.000301	0.00494	CcSEcCtD
Neostigmine—Arrhythmia—Prednisone—ankylosing spondylitis	0.0003	0.00492	CcSEcCtD
Neostigmine—Shock—Triamcinolone—ankylosing spondylitis	0.000297	0.00487	CcSEcCtD
Neostigmine—Insomnia—Prednisolone—ankylosing spondylitis	0.000296	0.00487	CcSEcCtD
Neostigmine—Shock—Methylprednisolone—ankylosing spondylitis	0.000296	0.00486	CcSEcCtD
Neostigmine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000295	0.00484	CcSEcCtD
Neostigmine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000295	0.00484	CcSEcCtD
Neostigmine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000295	0.00484	CcSEcCtD
Neostigmine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000294	0.00483	CcSEcCtD
Neostigmine—Mental disorder—Prednisone—ankylosing spondylitis	0.000294	0.00482	CcSEcCtD
Neostigmine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000294	0.00482	CcSEcCtD
Neostigmine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000292	0.0048	CcSEcCtD
Neostigmine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000291	0.00479	CcSEcCtD
Neostigmine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000291	0.00477	CcSEcCtD
Neostigmine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00029	0.00477	CcSEcCtD
Neostigmine—Convulsion—Betamethasone—ankylosing spondylitis	0.00029	0.00477	CcSEcCtD
Neostigmine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000281	0.00462	CcSEcCtD
Neostigmine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000277	0.00454	CcSEcCtD
Neostigmine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000275	0.00451	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000275	0.00451	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000274	0.0045	CcSEcCtD
Neostigmine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000274	0.00449	CcSEcCtD
Neostigmine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000274	0.00449	CcSEcCtD
Neostigmine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000273	0.00448	CcSEcCtD
Neostigmine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000272	0.00447	CcSEcCtD
Neostigmine—Shock—Dexamethasone—ankylosing spondylitis	0.000269	0.00442	CcSEcCtD
Neostigmine—Shock—Betamethasone—ankylosing spondylitis	0.000269	0.00442	CcSEcCtD
Neostigmine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000269	0.00441	CcSEcCtD
Neostigmine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000268	0.0044	CcSEcCtD
Neostigmine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000268	0.0044	CcSEcCtD
Neostigmine—Agitation—Prednisone—ankylosing spondylitis	0.000268	0.0044	CcSEcCtD
Neostigmine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000267	0.00438	CcSEcCtD
Neostigmine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000267	0.00438	CcSEcCtD
Neostigmine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000264	0.00434	CcSEcCtD
Neostigmine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000264	0.00434	CcSEcCtD
Neostigmine—Syncope—Prednisone—ankylosing spondylitis	0.000262	0.0043	CcSEcCtD
Neostigmine—Urticaria—Prednisolone—ankylosing spondylitis	0.00026	0.00428	CcSEcCtD
Neostigmine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000257	0.00421	CcSEcCtD
Neostigmine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000256	0.0042	CcSEcCtD
Neostigmine—Hypotension—Betamethasone—ankylosing spondylitis	0.000256	0.0042	CcSEcCtD
Neostigmine—Convulsion—Prednisone—ankylosing spondylitis	0.000253	0.00415	CcSEcCtD
Neostigmine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000253	0.00415	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000249	0.00409	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000249	0.00409	CcSEcCtD
Neostigmine—Arthralgia—Prednisone—ankylosing spondylitis	0.000248	0.00408	CcSEcCtD
Neostigmine—Insomnia—Betamethasone—ankylosing spondylitis	0.000247	0.00406	CcSEcCtD
Neostigmine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000247	0.00406	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000247	0.00405	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000246	0.00404	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000245	0.00403	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000242	0.00397	CcSEcCtD
Neostigmine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000239	0.00393	CcSEcCtD
Neostigmine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000239	0.00392	CcSEcCtD
Neostigmine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000238	0.00391	CcSEcCtD
Neostigmine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000238	0.0039	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000236	0.00388	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000236	0.00388	CcSEcCtD
Neostigmine—Shock—Prednisone—ankylosing spondylitis	0.000234	0.00385	CcSEcCtD
Neostigmine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000234	0.00384	CcSEcCtD
Neostigmine—Tachycardia—Prednisone—ankylosing spondylitis	0.000232	0.00382	CcSEcCtD
Neostigmine—Skin disorder—Prednisone—ankylosing spondylitis	0.000231	0.0038	CcSEcCtD
Neostigmine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00023	0.00378	CcSEcCtD
Neostigmine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000224	0.00367	CcSEcCtD
Neostigmine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000224	0.00367	CcSEcCtD
Neostigmine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000222	0.00365	CcSEcCtD
Neostigmine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000222	0.00364	CcSEcCtD
Neostigmine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000217	0.00357	CcSEcCtD
Neostigmine—Urticaria—Betamethasone—ankylosing spondylitis	0.000217	0.00357	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000217	0.00356	CcSEcCtD
Neostigmine—Dizziness—Prednisolone—ankylosing spondylitis	0.000217	0.00356	CcSEcCtD
Neostigmine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000216	0.00355	CcSEcCtD
Neostigmine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000216	0.00355	CcSEcCtD
Neostigmine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000216	0.00355	CcSEcCtD
Neostigmine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000216	0.00354	CcSEcCtD
Neostigmine—Insomnia—Prednisone—ankylosing spondylitis	0.000215	0.00354	CcSEcCtD
Neostigmine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000213	0.0035	CcSEcCtD
Neostigmine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000213	0.00349	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—ankylosing spondylitis	0.000211	0.00347	CcSEcCtD
Neostigmine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000208	0.00341	CcSEcCtD
Neostigmine—Rash—Prednisolone—ankylosing spondylitis	0.000207	0.00339	CcSEcCtD
Neostigmine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000206	0.00339	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000206	0.00339	CcSEcCtD
Neostigmine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000206	0.00338	CcSEcCtD
Neostigmine—Headache—Prednisolone—ankylosing spondylitis	0.000205	0.00337	CcSEcCtD
Neostigmine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000199	0.00327	CcSEcCtD
Neostigmine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000199	0.00327	CcSEcCtD
Neostigmine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000199	0.00327	CcSEcCtD
Neostigmine—Asthenia—Betamethasone—ankylosing spondylitis	0.000196	0.00322	CcSEcCtD
Neostigmine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000196	0.00322	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000195	0.00321	CcSEcCtD
Neostigmine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000195	0.0032	CcSEcCtD
Neostigmine—Nausea—Prednisolone—ankylosing spondylitis	0.000195	0.0032	CcSEcCtD
Neostigmine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000194	0.00318	CcSEcCtD
Neostigmine—Pruritus—Betamethasone—ankylosing spondylitis	0.000194	0.00318	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000193	0.00318	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000192	0.00316	CcSEcCtD
Neostigmine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000192	0.00315	CcSEcCtD
Neostigmine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000191	0.00314	CcSEcCtD
Neostigmine—Rash—Triamcinolone—ankylosing spondylitis	0.00019	0.00312	CcSEcCtD
Neostigmine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00019	0.00312	CcSEcCtD
Neostigmine—Rash—Methylprednisolone—ankylosing spondylitis	0.00019	0.00311	CcSEcCtD
Neostigmine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000189	0.00311	CcSEcCtD
Neostigmine—Urticaria—Prednisone—ankylosing spondylitis	0.000189	0.00311	CcSEcCtD
Neostigmine—Headache—Triamcinolone—ankylosing spondylitis	0.000189	0.0031	CcSEcCtD
Neostigmine—Headache—Methylprednisolone—ankylosing spondylitis	0.000188	0.00309	CcSEcCtD
Neostigmine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000188	0.00309	CcSEcCtD
Neostigmine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000187	0.00307	CcSEcCtD
Neostigmine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000187	0.00307	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—ankylosing spondylitis	0.000186	0.00305	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000181	0.00298	CcSEcCtD
Neostigmine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000181	0.00297	CcSEcCtD
Neostigmine—Dizziness—Betamethasone—ankylosing spondylitis	0.000181	0.00297	CcSEcCtD
Neostigmine—Insomnia—Methotrexate—ankylosing spondylitis	0.00018	0.00296	CcSEcCtD
Neostigmine—Nausea—Triamcinolone—ankylosing spondylitis	0.000179	0.00294	CcSEcCtD
Neostigmine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000179	0.00293	CcSEcCtD
Neostigmine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000177	0.00291	CcSEcCtD
Neostigmine—Somnolence—Methotrexate—ankylosing spondylitis	0.000177	0.00291	CcSEcCtD
Neostigmine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000176	0.00288	CcSEcCtD
Neostigmine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000174	0.00286	CcSEcCtD
Neostigmine—Vomiting—Betamethasone—ankylosing spondylitis	0.000174	0.00286	CcSEcCtD
Neostigmine—Rash—Betamethasone—ankylosing spondylitis	0.000172	0.00283	CcSEcCtD
Neostigmine—Rash—Dexamethasone—ankylosing spondylitis	0.000172	0.00283	CcSEcCtD
Neostigmine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000172	0.00283	CcSEcCtD
Neostigmine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000172	0.00283	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000172	0.00282	CcSEcCtD
Neostigmine—Headache—Betamethasone—ankylosing spondylitis	0.000171	0.00281	CcSEcCtD
Neostigmine—Headache—Dexamethasone—ankylosing spondylitis	0.000171	0.00281	CcSEcCtD
Neostigmine—Asthenia—Prednisone—ankylosing spondylitis	0.000171	0.00281	CcSEcCtD
Neostigmine—Pruritus—Prednisone—ankylosing spondylitis	0.000169	0.00277	CcSEcCtD
Neostigmine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000163	0.00268	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000163	0.00267	CcSEcCtD
Neostigmine—Nausea—Betamethasone—ankylosing spondylitis	0.000162	0.00267	CcSEcCtD
Neostigmine—Nausea—Dexamethasone—ankylosing spondylitis	0.000162	0.00267	CcSEcCtD
Neostigmine—Urticaria—Methotrexate—ankylosing spondylitis	0.000158	0.0026	CcSEcCtD
Neostigmine—Dizziness—Prednisone—ankylosing spondylitis	0.000158	0.00259	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000157	0.00258	CcSEcCtD
Neostigmine—Vomiting—Prednisone—ankylosing spondylitis	0.000151	0.00249	CcSEcCtD
Neostigmine—Rash—Prednisone—ankylosing spondylitis	0.00015	0.00247	CcSEcCtD
Neostigmine—Dermatitis—Prednisone—ankylosing spondylitis	0.00015	0.00246	CcSEcCtD
Neostigmine—Headache—Prednisone—ankylosing spondylitis	0.000149	0.00245	CcSEcCtD
Neostigmine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000147	0.00241	CcSEcCtD
Neostigmine—Asthenia—Methotrexate—ankylosing spondylitis	0.000143	0.00235	CcSEcCtD
Neostigmine—Nausea—Prednisone—ankylosing spondylitis	0.000141	0.00232	CcSEcCtD
Neostigmine—Pruritus—Methotrexate—ankylosing spondylitis	0.000141	0.00231	CcSEcCtD
Neostigmine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000136	0.00224	CcSEcCtD
Neostigmine—Dizziness—Methotrexate—ankylosing spondylitis	0.000132	0.00216	CcSEcCtD
Neostigmine—Vomiting—Methotrexate—ankylosing spondylitis	0.000127	0.00208	CcSEcCtD
Neostigmine—Rash—Methotrexate—ankylosing spondylitis	0.000126	0.00206	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000125	0.00206	CcSEcCtD
Neostigmine—Headache—Methotrexate—ankylosing spondylitis	0.000125	0.00205	CcSEcCtD
Neostigmine—Nausea—Methotrexate—ankylosing spondylitis	0.000118	0.00194	CcSEcCtD
